20-May-2024
No headlines found.
Business Wire (Thu, 2-May 4:05 PM ET)
Tandem Diabetes Care Announces Upcoming Conference Presentations
Business Wire (Mon, 29-Apr 4:05 PM ET)
Globe Newswire (Tue, 23-Apr 9:00 PM ET)
Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
Business Wire (Tue, 9-Apr 4:05 PM ET)
Parexel Announces CEO Succession Plan
Globe Newswire (Mon, 18-Mar 9:05 AM ET)
Business Wire (Wed, 6-Mar 12:46 AM ET)
Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes
Business Wire (Mon, 4-Mar 4:05 PM ET)
Business Wire (Wed, 21-Feb 4:05 PM ET)
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.
Tandem Diabetes Care trades on the NASDAQ stock market under the symbol TNDM.
As of May 20, 2024, TNDM stock price declined to $47.23 with 1,135,638 million shares trading.
TNDM has a beta of 1.45, meaning it tends to be more sensitive to market movements. TNDM has a correlation of 0.06 to the broad based SPY ETF.
TNDM has a market cap of $3.10 billion. This is considered a Mid Cap stock.
Last quarter Tandem Diabetes Care reported $192 million in Revenue and -$.64 earnings per share. This beat revenue expectation by $18 million and exceeded earnings estimates by $.12.
In the last 3 years, TNDM stock traded as high as $155.86 and as low as $13.82.
The top ETF exchange traded funds that TNDM belongs to (by Net Assets): IJR, VTI, VB, VXF, VBK.
TNDM has outperformed the market in the last year with a price return of +55.3% while the SPY ETF gained +29.3%. TNDM has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +93.4% and +5.6%, respectively, while the SPY returned +6.4% and +3.7%, respectively.
TNDM support price is $45.58 and resistance is $49.02 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TNDM stock will trade within this expected range on the day.